| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/06/2006 | WO2006052568A3 Tgf-beta inhibitors |
| 07/06/2006 | WO2006044933A3 Compositions and methods for disruption of brca2-rad51 interaction |
| 07/06/2006 | WO2006044503A3 Compounds for nonsense suppression, use of these compounds for the manufacture of a medicament for treating somatic mutation-related diseases |
| 07/06/2006 | WO2006043031A3 Class iii slrp for the treatment of cancer |
| 07/06/2006 | WO2006033006A3 Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor |
| 07/06/2006 | WO2006017672A3 2, 8-disubstituted naphthyridine derivatives |
| 07/06/2006 | WO2006014335A3 Compositions and methods for treatment of non-hodgkin’s lymphoma |
| 07/06/2006 | WO2006000830A3 Cells expressing a modified t cell receptor |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
| 07/06/2006 | US20060149066 Imidazole derivatives |
| 07/06/2006 | US20060149045 Steroid compounds with anti-tumor activity |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148908 Supressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148848 Compounds and methods for treating cancer and inflammation |
| 07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 07/06/2006 | US20060148828 Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148804 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148788 Pyrrolobenzodiazepines |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148733 Composition containing total triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 07/06/2006 | US20060148728 Novel podophyllotoxin compositions |
| 07/06/2006 | US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148678 Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148064 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 07/06/2006 | US20060148045 Composition containing lactic acid bacterium producing equol |
| 07/06/2006 | US20060148032 Novel phosphoprotein |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 07/06/2006 | US20060147551 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/06/2006 | US20060147478 Protein involved in carcinoma |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147434 Different dendritic cell subsets |
| 07/06/2006 | US20060147374 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | US20060147373 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | DE19854628B4 Verwendung von Pflanzenteilen oder Extrakten von Planzen aus der Gattung Rhus der Familie der Anacardiaceae zur Herstellung eines Arzneimittels zum Schutz vor genotoxischen Einflüssen Use of plant parts or extracts of Planzen from the genus Rhus of Anacardiaceae family for preparing a medicament to protect against the genotoxic effects |
| 07/06/2006 | DE102005054092A1 Stereoisomer angereicherte 3-Aminocarbonyl-Bicyclohepten-Pyrimidindiamin-Verbindungen und deren Anwendungen Stereoisomer enriched 3-aminocarbonyl-bicycloheptene pyrimidinediamine compounds and their applications |
| 07/06/2006 | CA2594345A1 Compositions and methods of treating cell proliferation disorders |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2594245A1 Retrotransposon inhibition in therapy |
| 07/06/2006 | CA2593993A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | CA2593086A1 Anti-tumoral immunogenic peptides and vaccine thereof |
| 07/06/2006 | CA2593035A1 Pharmaceutical compositions for treating diseases associated with nf-.kappa.b activity |
| 07/06/2006 | CA2592972A1 Methods to bypass cd+4 cells in the induction of an immune response |
| 07/06/2006 | CA2592968A1 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 07/06/2006 | CA2592509A1 Benzazole analogues and uses thereof |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2590961A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | CA2589374A1 Antibodies directed to gpnmb and uses thereof |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676915A2 Ribozyme therapy for the treatment of proliferative skin diseases |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676862A1 Recombinant antibody against human insulin-like growth factor |
| 07/05/2006 | EP1676855A2 Prenyl transferase inhibitors |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1676577A1 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide |
| 07/05/2006 | EP1676576A1 Combinations comprising camptothecin and their use for the treatment of neoplastic diseases |
| 07/05/2006 | EP1675873A1 Correlation between the fucose content / galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 07/05/2006 | EP1675861A1 Pyrimidothiophene compounds |
| 07/05/2006 | EP1675848A1 Novel triarylimidazoles |
| 07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 07/05/2006 | EP1675834A1 Compounds, compositions, and methods |
| 07/05/2006 | EP1675616A2 Novel igg3 antibodies for stimulating phagocytosis |
| 07/05/2006 | EP1675599A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof |
| 07/05/2006 | EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675465A2 Improved combination bacteriolytic therapy for the treatment of tumors |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1259240B1 Agents, such as nicotinamide or cadpr for the treatment of skin disorders |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1161250B9 Immunostimulant bacterial membrane fractions in cancer treatment |
| 07/05/2006 | EP1141318B1 P450 / acetaminophen gdept for cancer treatment |
| 07/05/2006 | EP1133522B1 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |